AWM
QTTB icon

Ameliora Wealth Management’s Q32 Bio QTTB Stock Holding History

Ameliora Wealth Management’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-83
Closed -$912 – 207
2023
Q4 		$912 Hold
83
– – ﹤0.01% 181
2023
Q3 		$1.75K Hold
83
– – ﹤0.01% 211
2023
Q2 		$1.33K Hold
83
– – ﹤0.01% 189
2023
Q1 		$1.54K Hold
83
– – ﹤0.01% 207
2022
Q4 		$1.89K Hold
83
– – ﹤0.01% 220
2022
Q3 		$2K Buy
+83
New +$3.38K ﹤0.01% 217

Other funds holding QTTB

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ameliora Wealth Management's QTTB Position: Q1 2024 in Review

Ameliora Wealth Management sold out of Q32 Bio (QTTB) in Q1 2024, closing a stake of 83 shares — an estimated $912 sold.

Ameliora Wealth Management first reported a position in QTTB in Q3 2022 and held it in 6 quarters. The position peaked at $2K in Q3 2022. 39 funds tracked by Wall St. Rank hold QTTB as of Q1 2024.

  • Ameliora Wealth Management reported no remaining Q32 Bio position as of Q1 2024 after selling out during the quarter.
  • Ameliora Wealth Management sold 83 Q32 Bio shares in Q1 2024, an estimated $912.
  • Ameliora Wealth Management first reported a position in Q32 Bio in Q3 2022 and held it in 6 quarters.
  • Ameliora Wealth Management's Q32 Bio position peaked at $2K in Q3 2022.
  • 39 funds tracked by Wall St. Rank held Q32 Bio as of Q1 2024.

Based on Ameliora Wealth Management's 13F filing for Q1 2024, filed 16 Apr 2024.